Skip to content

A Clinical Trial on a Group Treatment for Distressed Caregivers of Cancer Patients

Addressing the Hidden Patient - A Randomised-controlled Trial of a Tailored Group Intervention for Caregivers of Cancer Patients (PREPARE)

Status
Withdrawn
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02739243
Acronym
PREPARE
Enrollment
0
Registered
2016-04-15
Start date
2016-04-30
Completion date
2016-10-31
Last updated
2016-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distress in Caregivers of Cancer Patients

Brief summary

Background and study aims: Being a caregiver for someone with cancer can be very difficult emotionally. For many the patient is a family member or friend, and so this can cause the caregiver a great deal of psychological distress. There are currently very few studies looking into the effectiveness of psychological treatments for distressed caregivers of cancer patients. This study is looking at tailored group therapy program for carers of cancer givers. The aim of this study is to find out whether this program can help to lower levels of distress in cancer caregivers and help them to better cope with caring for someone with the illness.

Interventions

BEHAVIORALTailored group intervention (PREPARE)
BEHAVIORALIndividual treatment as usual

Sponsors

Heidelberg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Time since initial diagnosis (of patient) not longer than six months previously 2. Significant distress against the background of the cancer disease (QSC-R10C exceeding 16 points) 3. Provision of informed consent 4. Aged 18 or over, either gender

Exclusion criteria

1. Inability to give informed consent 2. Insufficient German language knowledge 3. Cognitive impairment impeding handling of questionnaires 4. Severe psychiatric disease (acute psychosis or acute suicidality)

Design outcomes

Primary

MeasureTime frameDescription
Distresschange from baseline distress at 1 week post treatmentmeasured using the Questionnaire on Stress in Caregivers of Cancer Patients Revised version (QSC-R10C)

Secondary

MeasureTime frameDescription
Depressionchange from baseline depression at 1 week post treatment and at 6 months post treatmentmeasured using the Patient Health Questionnaire-9 (PHQ-9)
General distresschange from baseline general distress at 1 week post treatment and at 6 months post treatmentmeasured using the Distress Thermometer (NCCN DT)
Unmet needschange from baseline unmet needs at 1 week post treatment and at 6 months post treatmentmeasured using the Supportive Care Needs Survey - Partners & Caregivers (SCNS-P&C-G)
Anxietychange from baseline anxiety at 1 week post treatment and at 6 months post treatmentmeasured using the Generalized Anxiety Disorder-7 (GAD-7)
Utilisation of primary healthcarechange from baseline to 1 week post treatment and 6 months post treatmentmeasured via the number of visits with the individual primary care physician
Positive bonding with the groupchange from baseline bonding at 1 week post treatment and 6 months post treatmentmeasured via the Positive Bonding Scale of the Group Questionnaire (GQ-D)
Self-efficacy in coping with the cancer diseasechange from baseline self-efficacy at 1 week post treatment and at 6 months post treatmentmeasured using the adapted General Perceived Self-Efficacy Scale

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026